READ PHARMA DEVELOPMENT
Business purpose.
La réalisation de prestations pour le développement d'activités pharmaceutiques et de biotechnologies.
Identity
- Legal form
- SARL (no further detail)
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 17 Apr 2018
- Share capital
- 50,000.00 EUR
- Registered with the trade register
- 19 Apr 2018
- Financial year end
- 30/09
- Establishments
- 1
Directors
- Adrien REYMOND 44 years old, 09/1982 Gerant et associe indefiniment responsable
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- ADRIEN REYMOND via Adrien REYMOND
Other companies at the same address
One other company head office is registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
77 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (8.6 years)
- 17.2 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Legal notices
-
Filing of accounts 22 Feb 2026
- Court :
- Greffe du Tribunal de Commerce de nantes
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2025
BODACC C n 20260036, annonce n 2024 · Proof of publication (PDF)
-
Filing of accounts 28 Mar 2025
- Court :
- Greffe du Tribunal de Commerce de nantes
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2024
BODACC C n 20250062, annonce n 1593 · Proof of publication (PDF)
-
Filing of accounts 13 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de nantes
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2023
BODACC C n 20240030, annonce n 2346 · Proof of publication (PDF)
-
Filing of accounts 16 Apr 2023
- Court :
- Greffe du Tribunal de Commerce de nantes
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2022
BODACC C n 20230075, annonce n 2012 · Proof of publication (PDF)
-
Filing of accounts 19 Jan 2022
- Court :
- Greffe du Tribunal de Commerce de nantes
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2021
BODACC C n 20220013, annonce n 2728 · Proof of publication (PDF)
-
Filing of accounts 4 Mar 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE NANTES
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2020
BODACC C n 20210044, annonce n 5991 · Proof of publication (PDF)
-
Filing of accounts 18 Feb 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE NANTES
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2019
BODACC C n 20200034, annonce n 1204 · Proof of publication (PDF)
Filings and accounts
- Formality 2 Mar 2026
- Formality 16 Feb 2026
Change history
- officer_appointed (empty) → Gerant et associe indefiniment responsable 9 Oct 2026
Frequently asked questions about READ PHARMA DEVELOPMENT
- What is the SIREN number of READ PHARMA DEVELOPMENT?
- The SIREN number of READ PHARMA DEVELOPMENT is 839097755. Its intra-community VAT number is FR08839097755.
- Where is the head office of READ PHARMA DEVELOPMENT?
- Head office address: 10 RUE MOLAC, 44000 NANTES.
- When was READ PHARMA DEVELOPMENT founded?
- READ PHARMA DEVELOPMENT was founded on 17 Apr 2018.
- What does READ PHARMA DEVELOPMENT do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs READ PHARMA DEVELOPMENT?
- The officer listed in the register is Adrien REYMOND (Gerant et associe indefiniment responsable).
- Is READ PHARMA DEVELOPMENT subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.